Founded in early 2003, DNA2.0 is a privately-held, leading synthetic biology company, headquartered in Menlo Park, CA. It is the largest US provider of synthetic genes, with a global customer base comprised of academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries.